Advertisement
Indian
India’s insurance penetration expands by 12% to 4.20% 2020-21,non-life penetration hits 1%
Atul Sahai, CMD, New India Assurance and chairman of General...
Incurred claims of standalone health insurers grow at slower pace in Covid-hit FY21
As per the Annual Report 2020-21, the net incurred claims of the...
Odisha CM launches livelihood assistance to beneficiaries of Biju Swasthya Kalyan Yojana
Chief Minister said, "the welfare programs for the poor is the most...
Haryana makes second dose of Covid vaccination mandatory from Jan 1, 2022
"From January 1, 2022, any eligible person who has not taken both...
International
From Parkinson’s to peanut allergy, pandemic puts brakes on new drugs
Neurocrine Chief Executive Kevin Gorman said in an interview that many neurologists had been redirected to fighting the pandemic, leading to delaying Ongentys until later in 2020. The delay to Palforzia, Aimmune’s sole approved drug, means the company will not generate any revenue until later this year, prompting it to halt new hires in a bid to preserve its $370 million of cash.
Millions at risk in Bangladesh as monsoon floods add to coronavirus worries
“The disaster is worsening by the hour, with several hundred thousands already severely affected by the floods, worsening the COVID pandemic and crisis in the country,” said Antony Balmain, a spokesman for the International Federation of Red Cross and Red Crescent Societies.
Bangladesh had 149,258 confirmed coronavirus cases as of Wednesday, with 1,888 deaths.
Bank of England tells banks & insurers to push on with climate risk analysis
The guide drawn up by the Climate Financial Risk Forum (CFRF),which was set up by the BoE and Britain’s Financial Conduct Authority last year, is the first of its kind and sets out how financial firms can analyze and disclose risks from climate change and spot opportunities for new consumer products.Sarah Breeden, the BoE’s co-chair of the CFRF, said firms should start on their analyses straight away using the guide that is based on best practice from firms
Tesla sued for airbag malfunction in Model 3 highway crash
Alleged defects in Tesla’s Autopilot system have been blamed in several lawsuits for deaths and injuries and the company has faced scrutiny of the technology by federal safety regulators. Separately, the National Highway Traffic Safety Administration is investigating premature failures of the large central touchscreen and the computer that powers it in Tesla’s Model S sedans.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.